Work

No Clinical Evidence for Increase in Tumour Malignant Potential in Patients (Pts) with Metastatic Breast Cancer (mBC) Treated with Bevacizumab (BV) and Docetaxel (D) in the Phase III AVADO Study.

Year: 2009

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs-09-6086

Authors: N. Harbeck, A. Chan, D. ten Bokkel Huinink, P. Chollet, D. Gimenes, C. Fabiani, S. Salvagni, L. Pérez-Michel, A. Schneeweiss, A. Chlistalla, D. Miles

Institutions: University of Cologne, Diakonessenhuis hospital, Centre Jean Perrin, AC Camargo Hospital, Hospital de Câncer de Barretos, Ospedale di Parma, Heidelberg University, F. Hoffmann-La Roche AG, Mount Vernon Cancer Centre

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2066898998

Cites:

Cited by: 7

Related to: 10